RxSight, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-12.1M | $-15.9M | $-9.8M | $-11.8M | $-8.2M | $-6.3M | $-6.1M | $-9.1M |
| Depreciation & Amortization | — | $834.0K | — | — | $776.0K | — | — | $1.1M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | $7.9M | — | — | $7.1M | — | — | $4.7M |
| Net Cash from Operating Activities | — | $-10.9M | — | — | $-8.8M | — | — | $-9.3M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $759.0K | — | — | $575.0K | — | — | $2.0M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $8.8M | — | — | $20.9M | — | — | $24.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $-336.0K | — | — | $-735.0K | — | — | $8.0M |
| Net Change in Cash | — | $-2.4M | — | — | $11.3M | — | — | $23.0M |
| Free Cash Flow | — | $-11.7M | — | — | $-9.4M | — | — | $-11.3M |